Selkirk Pharma, the Spokane-based manufacturer of injectable drug products, raised $24.1M in seed funding from undisclosed investors. This funding puts the company’s pre-money valuation at over $375M.
Founded in 2018, the pharmaceutical startup has a 147,700-square-foot manufacturing facility at 9119 W. Granite, on the West Plains, north of the Northwest Farm Credit Services headquarters. The facility is the first of three standalone manufacturing plants the company plans to build at its campus, the Journal reported last year.
In 2021, Selkirk Pharma purchased over 10 acres of land adjacent to its first facility, expanding the campus to over 27 acres total. According to a 2021 announcement on Selkirk Pharma’s website, all three facilities “will incorporate industry-leading technology, including isolator-based filling systems and electronic batch records.”